[1]
Asma Luqman and Qurat ul Ain Ghouri, “Comparison of the Effectiveness and Safety of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients with Overweight or Obesity”, JHWCR, vol. 3, no. 7, pp. 1–11, Jul. 2025, doi: 10.61919/q7nc4n17.